Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 2/2012

01.06.2012 | Original Article

Loss of Expression of DNA Mismatch Repair Proteins in Aberrant Crypt Foci Identified In Vivo by Magnifying Colonoscopy in Subjects with Hereditary Nonpolyposic and Sporadic Colon Rectal Cancer

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aims of this study are to characterize the frequency, density, and distribution of aberrant crypt foci (ACF) and its histological features and to determine the frequency of loss of expression of DNA mismatch repair (MMR) proteins of subjects with hereditary nonpolyposic colorectal cancer (HNPCC) and sporadic colon rectal cancer (CRC).

Methods

Patients with HNPCC, first-degree relatives of subjects with HNPCC, sporadic CRC, and average risk subjects of sporadic CRC were included prospectively. Total colonoscopy with chromoendoscopy using methylene blue 0.5% and magnification in the right colon (cecum and 20 cm of the ascending colon) and in the left colon (rectum) was performed; loss of expression of MLH1 and MSH2 was evaluated by immunohistochemistry in confirmed ACF.

Results

Fifty-two subjects were included. Thirty-eight of the 119 ACF detected by endoscopy were biopsied. In 14 of the 38 specimens (36.8%), ACF were confirmed by histology (Cohen's kappa, 0.44). In subjects with HNPCC, ACF were identified more frequently in the right segment of the colon than in the left (73.1% vs. 26%); in contrast, ACF predominated in the left segment of the colon (89.3% vs. 10.6%) in subjects with sporadic CRC. There was a loss of MLH1 expression in ACF in subjects with HNPCC.

Conclusions

In HNPCC, we found a greater density of ACF in the right colon, and in sporadic CRC, greater density in the left. ACF present loss in the expression of DNA MMR protein and can be used as an early marker in patients with a risk of HNPCC in whom carcinogenesis appears to be accelerated.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
3.
Zurück zum Zitat DeFrancisco J, Grady WM. Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc. 2003;58:390–408.PubMedCrossRef DeFrancisco J, Grady WM. Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc. 2003;58:390–408.PubMedCrossRef
4.
Zurück zum Zitat Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 2001;121:198–213.PubMedCrossRef Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 2001;121:198–213.PubMedCrossRef
5.
Zurück zum Zitat Lubinski J, Lynch HT, Lynch J, et al. HNPCC (Lynch syndrome): differential diagnosis, molecular genetics and management—a review. Hered Cancer Clin Prac. 2003;1:7–18.CrossRef Lubinski J, Lynch HT, Lynch J, et al. HNPCC (Lynch syndrome): differential diagnosis, molecular genetics and management—a review. Hered Cancer Clin Prac. 2003;1:7–18.CrossRef
6.
Zurück zum Zitat Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996;2:169–74.PubMedCrossRef Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996;2:169–74.PubMedCrossRef
7.
Zurück zum Zitat Boland CR, Koi M, Chang DK, et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer. 2008;7:41–52.PubMedCrossRef Boland CR, Koi M, Chang DK, et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer. 2008;7:41–52.PubMedCrossRef
8.
Zurück zum Zitat Piñol V, Castells A, Andreu M, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293:1986–94.PubMedCrossRef Piñol V, Castells A, Andreu M, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293:1986–94.PubMedCrossRef
9.
Zurück zum Zitat Müller A, Giuffre G, Edmonston TB, et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mo Diagn. 2004;6:308–15.CrossRef Müller A, Giuffre G, Edmonston TB, et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mo Diagn. 2004;6:308–15.CrossRef
10.
Zurück zum Zitat Overbeek LI, Ligtenberg MJ, Willems RW, et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008;32:1246–51.PubMedCrossRef Overbeek LI, Ligtenberg MJ, Willems RW, et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008;32:1246–51.PubMedCrossRef
11.
Zurück zum Zitat Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535–49.PubMed Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535–49.PubMed
12.
Zurück zum Zitat Church J. Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance. Am J Gastroenterol. 1998;93:2289–90.PubMedCrossRef Church J. Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance. Am J Gastroenterol. 1998;93:2289–90.PubMedCrossRef
14.
Zurück zum Zitat Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1997–81.CrossRef Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1997–81.CrossRef
15.
Zurück zum Zitat Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–5.PubMedCrossRef Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–5.PubMedCrossRef
16.
Zurück zum Zitat Davila RE, Rajan E, Baron TH, et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63:546–57.PubMedCrossRef Davila RE, Rajan E, Baron TH, et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63:546–57.PubMedCrossRef
17.
Zurück zum Zitat Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary finding. Cancer Lett. 1987;37:147–51.PubMedCrossRef Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary finding. Cancer Lett. 1987;37:147–51.PubMedCrossRef
18.
Zurück zum Zitat Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplasic foci in human colonic mucosa. Cancer Res. 1991;51:1564–7.PubMed Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplasic foci in human colonic mucosa. Cancer Res. 1991;51:1564–7.PubMed
19.
Zurück zum Zitat Roncucci L, Pedroni M, Vaccina F, et al. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33:1–18.PubMedCrossRef Roncucci L, Pedroni M, Vaccina F, et al. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33:1–18.PubMedCrossRef
20.
Zurück zum Zitat Alrawi SJ, Schiff M, Carroll RE, et al. Aberrant crypt foci. Anticancer Res. 2006;26:107–19.PubMed Alrawi SJ, Schiff M, Carroll RE, et al. Aberrant crypt foci. Anticancer Res. 2006;26:107–19.PubMed
21.
Zurück zum Zitat Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003;9:2642–9.PubMed Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003;9:2642–9.PubMed
22.
Zurück zum Zitat Hurlstone DP, Cross SS. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis. J Gastroenterol Hepatol. 2005;20:173–81.PubMedCrossRef Hurlstone DP, Cross SS. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis. J Gastroenterol Hepatol. 2005;20:173–81.PubMedCrossRef
23.
Zurück zum Zitat Yamashita N, Minamoto T, Ochiai A, et al. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: is there preference among K-ras mutants for malignant progression? Cancer. 1995;75:1527–33.PubMedCrossRef Yamashita N, Minamoto T, Ochiai A, et al. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: is there preference among K-ras mutants for malignant progression? Cancer. 1995;75:1527–33.PubMedCrossRef
24.
Zurück zum Zitat Pedroni M, Sala E, Scarselli A, et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res. 2001;61:896–9.PubMed Pedroni M, Sala E, Scarselli A, et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res. 2001;61:896–9.PubMed
25.
Zurück zum Zitat Nucci MR, Robinson CR, Longo P, et al. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol. 1997;28:1396–407.PubMedCrossRef Nucci MR, Robinson CR, Longo P, et al. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol. 1997;28:1396–407.PubMedCrossRef
26.
Zurück zum Zitat Di Gregorio C, Losi L, Fante R, et al. Histology of aberrant crypt foci in the human colon. Histopathology. 1997;30:328–34.PubMedCrossRef Di Gregorio C, Losi L, Fante R, et al. Histology of aberrant crypt foci in the human colon. Histopathology. 1997;30:328–34.PubMedCrossRef
27.
Zurück zum Zitat Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.PubMedCrossRef Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.PubMedCrossRef
28.
Zurück zum Zitat Heinen CD, Shivapurkar N, Tang Z, et al. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. 1996;56:5339–41.PubMed Heinen CD, Shivapurkar N, Tang Z, et al. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. 1996;56:5339–41.PubMed
29.
Zurück zum Zitat Adler DG, Gostout CJ, Sorbi D, et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc. 2002;56:657–62.PubMedCrossRef Adler DG, Gostout CJ, Sorbi D, et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc. 2002;56:657–62.PubMedCrossRef
30.
Zurück zum Zitat Mutch MG, Schoen RE, Fleshman JW, et al. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol. 2009;7:568–74.PubMedCrossRef Mutch MG, Schoen RE, Fleshman JW, et al. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol. 2009;7:568–74.PubMedCrossRef
Metadaten
Titel
Loss of Expression of DNA Mismatch Repair Proteins in Aberrant Crypt Foci Identified In Vivo by Magnifying Colonoscopy in Subjects with Hereditary Nonpolyposic and Sporadic Colon Rectal Cancer
Publikationsdatum
01.06.2012
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 2/2012
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-011-9303-z

Weitere Artikel der Ausgabe 2/2012

Journal of Gastrointestinal Cancer 2/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.